chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 2 days of getting the vaccines client's eyes rolled back. He slumped over was unresponsive for a few mins. Client then pale, diaphoretic, low heart beat 58. BP 120/60. Client remained sleepy and appeared to be going in and out of consciousness. Client vomited. After 10 mins the EMS was called. Client taken to ER for further evaluation.
shingles; This initial spontaneous report was received on from a lawyer regarding a case in litigation and refers to a 57-year-old female patient. The patient's concurrent conditions, medical history and concomitant medication were not provided.   On 18-APR-2014, the patient was vaccinated with a dose zoster vaccine live (ZOSTAVAX) (dosage regimen was not reported) for the long-term prevention of shingles and/or zoster-related conditions.   On or about April 2014, the patient presented shingles. As a direct and proximate result, the patient had been caused to suffer severe personal injuries, pain, suffering and emotional distress, as well as to incur substantial economic damages. As a direct and proximate result, he suffered severe and permanent physical injuries, including but not limited to shingles, as well as other severe and permanent health consequences; additionally, he had incurred significant expenses for medical care and treatment, his injuries and damages were permanent and would continue into the future.   The reporter considered the event of shingles to be related to zoster vaccine live (ZOSTAVAX).
Patient reported Numbness in whole body , tingling, being sensitive to touch, and legs itching.  Started the evening after getting the shot and has episodes that last approximately 2 hours . Patient reports getting some relief with Benadryl.  He thought the adverse effects would slow down but remains.
The day after I took the vaccine I awaken with a terrible headache and remained in bed all day.  The next day I noticed a goose egg shape on my left arm in the area of the vaccine site, with soreness in my arm and shoulder throughout the entire week.   Called the pharmacy who suggested I complete the form online and contact the doctor.  Called the nurse line.
joint pain; This is a spontaneous report from a non-contactable consumer or other non hcp (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration on 19Jan2021 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunization. Medical history included arthritis from an unknown date and unknown if ongoing (some days are worse than others). The patient's concomitant medications were not reported. It was reported by the patient that after receiving the first dose of vaccine on an unspecified date in 2021 she experienced joint pain. She mentioned that she has some joint pain after the injection, not that bad. She was scheduled to get her second dose tomorrow (on an unspecified date). She already spoke to someone earlier if it was ok to take Tylenol. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Presented to the ED to be evaluated for covid like sx onset 6 weeks ago; admitted for COVID-19 pna; tx w/abx, Vit C, zinc, O2; pt weaned off of O2 and dc'd home
Information has been received from a Registered Nurse concerning her daughter (a 15 year old female) who in August 2008 was vaccinated with the third dose of GARDASIL (lot number was not available). The patient experienced leg weakness, dizziness, fatigue and syncope after receiving her third dose of vaccine. At the time of reporting the patient was not recovered. Follow-up AE Information was received from the Registered Nurse by phone concerning her daughter with no pertinent medical history and drug allergies who was vaccinated with her third dose of GARDASIL in April 2008 (not August 2008 as previously reported). Date of birth of the patient is 19-JUN-1993. Patient is not pregnant. Lot #s of GARDASIL are unspecified. Her symptoms began in October 2008. In addition to leg weakness, dizziness, fatigue and syncope the patient has also been experiencing seizure-like activity. No other vaccinations was administered with GARDASIL. Patient is on AVIANE birth control. The patient has seen a neurologist and has had an EEG, EMG of lower extremities and MRI of brain, MRI of abdomen and lab work. All tests have all come back negative. Dose 1 was administered on an unspecified date and dose 2 was administered on 09-SEP-2007. The patient's symptoms are getting worse. The syncope and seizure-like activity are occurring more often. No hospitalization, not life-threatening, not a significant disability. No treatment and no medication have been prescribed at this point. Upon internal review, seizure-like activity was determined to be an other important medical event. The patient sought medical attention. Additional information has been requested.  2/24/09 Received PCP medical records of 11/7/08, Records reveal patient experienced abdominal pain, dizziness, numbness & urinary incontinence x 1.  Refered to Neuro.  3/4/09 Received Neuro medical records of 11/18/2008-2/12/2009. FINAL DX: right peripheral vestibular dysfunction, vestibular neuronitis & restless leg syndrome Records reveal patient experienced episodes of disequilibrium & dizziness daily since 10/1/08; right leg numbness w/falls x 2 since 10/7/08; now w/numbness of right leg; urinary incontinence x 1; abdominal pain; fatigue; nausea; feelings of detachment or depersonalization x 8 mo.  Tx w/meds w/some improvement.
High fever of 103 F/ temperature increased; Chills; Terrible head ache; Body ache; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number; EN6207) via an unspecified route of administration in the left arm as a single dose for COVID-19 Immunisation on 17Mar2021 at 09:00 (at the age of 70-year-old). Medical history and concomitant medications were not reported. The patient was not allergic to any medications, food, or other products. The patient previously received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19, Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 17Mar2021 at 11:30, the patient experienced fever of 103 F/ increased temperature, chills, terrible head ache and body ache. Around midnight temperature increased and by the morning she ran high fever of 103 F and also had chills, terrible head ache, body ache, for 2 days. The patient did not take any treatment for the reported events. The clinical outcome of the fever of 103 F/ increased temperature, chills, terrible head ache and body ache was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown age and gender. No information about patients' medical history, concomitant medication and concurrent conditions were not reported. On an unspecified dates, the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB from lot # N000237 with expiry: 25-OCT-2019, prophylaxis. The vaccine lot was exposed to temperature of 0° C to 1° C for 30 hours and  -1° C or colder (-2°C) for 225 minutes (15 Cycles). The temperature excursion was detected by digital data logger. It had no previous temperature excursion. This is one of three reports received from the same reporter.
Fever; This is a spontaneous report from a Pfizer-sponsored program, received from a contactable consumer (patient). A female patient of an unspecified age received the second dose of BNT162B2 ( PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, it was reported that the patient got fever and wants to know if she can take aspirin. The outcome of the event was unknown.  Information about batch/lot number has been requested.
No other adverse events reported; Expired vaccine being administered to a patient; This spontaneous report has been received from a pharmacy technician referring to a patient of unspecified age and gender. The patient's pertinent medical history, concomitant medications, concurrent conditions, and previous drug reactions or allergies were not reported.   On 02-MAR-2022, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant human albumin (rha) (M-M-R II) 1 dose as prophylaxis (route of administration, dose, vaccine scheme, and anatomical site of vaccination were not reported; lot number T007235 has been verified to be valid, expiration date reported and established as 27-FEB-2022) (expired product administered).   The reporter inquired about the stability data of the expired vaccine. In addition, the reporter stated that the dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant human albumin (rha) (M-M-R II) was properly stored up through administration. No adverse events were reported (no adverse event).
Red Itching  entire body red rash  a week later after injection;  rash is still continuing 6 months later.Blood
Muscles in upper left arm began hurting slightly within ten minutes of vaccine.  Then, pain increased steadily.  By four hours after the vaccine my arm was virtually paralyzed.  I was in extreme pain and totally unable to move my left arm.  Took Benadryl and 600 mg. of Tylenol at that time.  Some motion was returned to arm within ten minutes of taking Benadryl.
My teeth became super sensitive to the point where I couldn't eat anything hot or cold, and even food or drink at room temperature caused pain, too. I also had a horrible, strong metallic taste in my mouth for 8 days. Even with that, I could taste anything I ate and was told there was no odor to my breath. The metallic taste went away, but my teeth are still sensitive. However, they are not as sensitive as they were the 8 days following the vaccine. I still have trouble eating or drinking anything hot or cold because of the sensitivity, but room temperature food or drink is fine.
right arm was feverish, painful and difficult to move; right arm was feverish, painful and difficult to move; right arm was feverish, painful and difficult to move; fatigued; developed a fever/reached 101.3 and was steady at 100 F for the duration of day/fever broke; piercing headache; sleepiness; This is a spontaneous report from a contactable consumer (patient) reporting for herself. A 49-year-old non-pregnant female patient (patient was not pregnant at the time of vaccination received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL9262, Expiry date: unknown), via an unspecified route of administration on 30Jan2021 at 09:15 am (Age at the time of vaccination was 49-years-old) at single dose on right arm for covid-19 immunisation. Medical history included hypertension an obesity. The patient did not have allergies to medications, food, or other products. Concomitant medication patient received within 2 weeks of vaccination included propranolol, triamterene, bupropion, valaciclovir hydrochloride. The patient reported that, within 4 hours of injection, on 31Jan2021 at 08:00 my right arm was feverish, painful and difficult to move. Within 8 hours, I became fatigued and developed a fever the next day at 8 am that reached 101.3 and was steady at 100 F for the duration of day. I also developed a piercing headache and sleepiness. At 1:45 am on 02Feb2021, my fever broke. My headache remained until 02Feb2021. The events were considered as non-serious. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No treatment was received for the adverse events. The patient recovered from the event headache on 02Feb2021 and recovered from other events on an unspecified date in 2021.
monovalent COVID-19 vaccine was administered as a booster shot instead of a bivalent. Patient did not have an adverse event or outcome.
Pt recvd 1st dose vax 30JNA92 & next day devel flu-like sx - h/a, vomiting, myalgia, t102.5; also had swelling, erythema, tenderness @ inject site; pt seen by MD tx pred; 4th day post vax muscles in lt arm hard; joint effusion; lost hair;
Initial and follow-up information has been received from a physician concerning an 18 year old female patient who on approximately 26-MAR-2007 was vaccinated in her left upper arm with a first dose of GARDASIL. About 4 days after the vaccination she developed 4 swollen lymph nodes in the injection site area, but the physician said the injection site did not drain to these lymph nodes. The physician recommended no treatment and was following up with the patient in 2 weeks. A blood count was done which was normal. At the time of this report, the outcome of the patient was unknown. Additional information has been requested.
Within 2 hours, I became very chilled and was running a fever. I could barely move my right arm. I also was very achy and had a headache. In the next half hour, I suddenly became tingly all over and very faint. I almost passed out. In 15 minutes, I felt some better, but my right arm continued to become tingly and the site of the injection hurt and burned. I am thankful that I was not driving when this happened. After a few hours, I regained the use of my right arm, but I was very weak the rest of the day and maintained a slight headache. I received a Typhoid Fever shot in my right arm shot and Hep. B and Tetanus/Diptheria in ny left arm.
RECEIVED AN EXPIRED VACCINE; This spontaneous report received from a health care professional concerned a 29 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 1805031, and expiry: 24-AUG-2021) dose was not reported, administered on 26-AUG-2021 for prophylactic vaccination. No concomitant medications were reported.  On 26-AUG-2021, the patient experienced received an expired vaccine. The action taken with covid-19 vaccine was not applicable. The outcome of received an expired vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20210931844, 20210932593, 20210932567, 20210932036, 20210932874, 20210933076, 20210931810, 20210931982, 20210931951 and 20210932240.
Second dose only: muscle aches, fatigue, mild headache, brain fog. Fatigue and brain fog have  continued since 5/5
Slight HA, sore arm.  Awoke next AM feeling nauseous, upper eyelids swollen, and eyes bloodshot.  Did precipitate her migraines, X 2-3 days.  Other than migraines, other symptoms gone after 24 hours.
On day after vaccine had chills and fever(99.7) for ~ 24 hours. Also had muscle and joint pain, very sore arm at injection site, mildly swollen lymph nodes. All noted on handout to be possible side effects.  ***Day 2 after vaccine has very red rash all over neck, chest, abdominal and back areas with some itching  that lasted ~ 72 hours but was less visible each day after initially noted. No medical treatment sought as resolved on its on
Information has been received from a health professional for GARDASIL, a Pregnancy Registry product, concerning a female who was vaccinated with GARDASIL. Subsequently the patient became pregnant. Follow-up information has been received from a certified nurse midwife for GARDASIL, a Pregnancy Registry product, concerning a 22 year old female with a history of 1 pregnancy and 1 live birth with no birth defects or infant complications and a history of low grade squamous intraepithelial lesion (LGSIL) - cervix neoplasm stage I (CIN I) and cervix neoplasm stage II (CIN II) who on 08-JUL-2009 was vaccinated with the first dose of GARDASIL (lot #661046/0546X). On 21-JUL-2009 an ultrasound test was performed for gestational dating and revealed a 9 week intrauterine pregnancy. Her LMP was unknown. Expected date of delivery was 17-FEB-2010. In follow-up the certified nurse midwife reported that on approximately 16-JUL-2009 the patient developed bacterial vaginosis (BV). The patient was treated with FLAGYL, 500mg, twice daily. On 19-FEB-2010, the patient experienced oligohydramnios during the labor/delivery and delivered a normal, healthy male baby with no congenital anomalies weighing 7 pounds, 6 ounces and APGAR score of 8/9. There was not diagnostic test during pregnancy. Additional information is not expected.
This case was reported by a physician and described the occurrence of injection site soreness in a 12-year-old female subject who was vaccinated with HAVRIX (GlaxoSmithKline), TWINRIX. On 23 March 2010 the subject received 1st dose of HAVRIX at 1440 ELISA units in the right arm and a dose of TWINRIX in the left arm. The dose of HAVRIX given was an inappropriate dose of drug administered. The subject should have received a pediatric dose of HAVRIX. The subject experienced injection site soreness following administration of TWINRIX. The vaccination was also a maladministration (asymptomatic/child too young). At the time of reporting the outcome of injection site soreness was unspecified. The event was considered unrelated to vaccination with HAVRIX and TWINRIX. Follow-up information was received on 13 April 2010 via healthcare professional who reported the subject had no diagnosis. At the time of the report, no other information was provided.
Patient complaint of left upper arm pain and itching since receiving vaccination. No fever, body aches or chills reported. 3 x 3 cm circular, tender, swollen, red area over injection site. Client treated for cellulitis with Keflex 500 mg x 1 every 6 hours for 7 days and ibuprofen 800 mg every 8 hours for pain and swelling.  Patient contacted on 02/15/2018 and reports symptoms are improving.
This spontaneous report was received from a nurse practitioner referring to a 73 year female patient. The patients concurrent conditions included allergy to: paraphenylenediamine, ciprofloxacin (CIPRO), meperidine hydrochloride (DEMEROL) and nonsteroidal anti-inflammatory drug (unspecified). There was no information provided about the patient's medical history, concomitant medications, drug reactions or allergies. On 24-MAY-2017, the patient received an injectable dose of PNEUMOVAX23 intramuscularly for routine vaccine (lot # N005096 with expiration date on 22-OCT-2018) (strength, dose, frequency and anatomical location were not reported). The patient said to the reporter that, on 24-MAY-2017 (also reported as "immediately after receiving the PNEUMOVAX23"), her arm began to get "red and swollen". The reporter stated that, on 25-MAY-2017 (also reported as "at the time of the follow up visit"), the patient's arm was "hot, swollen, itchy, indurated and red, from her elbow to her deltoid" (feeling hot, pruritus, and induration). On an unspecified date in 2017, the patient was placed on diphenhydramine hydrochloride (BENADRYL) as treatment for the events. At the time of reporting, the patient had not recovered from the events of erythema, peripheral swelling, feeling hot, pruritus, and induration. The relationhip between the vaccination with PNEUMOVAX23 and the events of erythema, peripheral swelling, feeling hot, pruritus, and induration was not provided. Additional information has been requested.
Pain increasing from day 1 and continues.  Provider seen on 10/11/2022.  X-rays and MRI ordered.  Physical therapy started 10/17/2022. MRI results show bicep tendonitis, rotator cuff tear.  Steroid shots in shoulder and bicep to help with inflammation and pain. Pain and physical therapy continues.
(L) - 11 in (R) - 9 3/4 in. Pneumococcal (PNEUMOVAX 23) given in (L) deltoid on 2/11/16 at about 8:00AM - soreness noted at noon - redness/sore noted at 5PM. Presented to clinic at 10:20AM on 2/12/16 with swelling, rash, hot to touch area in outer/inner aspect of upper (L) arm. (T) - 98.3. 2/13/16 8:30AM Temp: 97.3 B/P 148/74 (R) arm (sitting) P: 76 Reg. Patient returns for recheck of PNEUMOVAX 23 adverse reaction. (Vaccine given 2/11/16. Pt. to clinic 2/12/16 for adverse reaction). Today (L) arm measures 10 1/2 inches. (2/12/16 measured 11"). (L) arm not as swollen. Upper (L) arm - deltoid - not as reddened or warm to touch as on 2/12/16. Redness of inner (L) arm increased from 2/12/16. On 2/12/16 was to elbow, today 3 1/2" below elbow. Pt states arm is feeling better, and inner (L) arm itching. Pt states she had BENADRYL x 2 on 2/12/16 with last dose approx. at 11:00 pm. Pt also has been applying ice to (L) arm. Dr. informed of above information and saw pt. Dr. instructed pt to return Monday if any problems or area not improved.
First Dose was EL0124 on 9 Jan 21.  As far as I know, my health was excellent until 3 Sep 21 when my cuff monitor displayed irregular pulse rate of 48 BPM.  Went to doctor the following Monday and was diagnosed with Bradey Cardia, Tachey Cardia, Irregular Heartbeat, and AFIB.   Was placed on pacemaker on 15 Nov 21.
Pain and swelling in the elbow of the opposite arm of the shot.  Some redness, stiffness and a lot of swelling a little over 24 hours after the covid-19 shot.
arm became cold; Blood pressure increased to 202/90; Heart rate increased to 105 bpm; A spontaneous report from was received from a non HCP concerning a 83 years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced arm became cold, blood pressure increased to 202/90, and heart rate increased to 105 bpm.  The patient's medical history was not provided.   On 27 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 007M20A) intramuscularly in the Arm for prophylaxis of COVID-19 infection.   On 27 Jan 2021, the patient was transported to emergency room with arm became cold, blood pressure increased to 202/90, and heart rate of 105 bpm. She was released from hospital 4 hrs. later.  At home, her blood pressure was 178/92 and heart rate 105bpm.  Action taken with mRNA-1273 in response to the events was not reported.    The outcome of the events was resolved on 28 Jan 2021.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the events, a causal relationship cannot be excluded.
tight chested,  chest pain, shortness of breath, double vision, blurry vision, extreme headache (primarily on the left side) mental confusion, slurred speach, dizziness, trouble walking, and I fainted two or three times 11/6 and again 11/8 My d-dimer and c-reactive proteins were elevated.  Elevated and uncontrollable BP
Raised red rash under injection site. 2.5 inches long by 1.5 inches long. Slightly sensitive to touch. Feels like mass under rash. Underarm also sore
Vaccine given Thursday 4/10/03 approx. 5pm-soreness noted Friday 4/11/03-am arm swollen from injection site-elbow-also red and hot to touch.